Offerings / Regulation CF / Arbela Laboratories, Inc.
Arbela Laboratories, Inc.
Regulation Crowdfunding offering on Wefunder · Form C filed October 8, 2026 · Randolph, New Jersey
Repeat issuerSAFEEarly revenueCorporation, Delaware
Business summary pending extraction from the offering statement. The company is a corporation organized in Delaware on January 31, 2020, based in Randolph, NJ, with 1 employees and $11,280 of revenue in its most recent fiscal year.
Offering terms
- Security
- Simple Agreement for Future Equity (SAFE)
- Maximum
- $124,000.00
- Price
- $1.00 per unit
- Pricing method
- Pro-rated portion of the total principal value of $50,000; interests will be sold in increments of $1; each investment is convertible to one share of stock as described under Item 13.
- Deadline
- April 30, 2027
- Oversubscriptions
- Accepted
- Intermediary
- Wefunder Portal LLC
Funding portal, SEC file 007-00033 - Intermediary fee
- 7.9% of the offering amount upon a successful fundraise, and be entitled to reimbursement for out-of-pocket third party expenses it pays or incurs on behalf of the Issuer in connection with the offering.
- Intermediary equity
- No
- Co-issuer
- Avaia Nutrition I, a series of Wefunder SPV, LLC
Financials as filed
| Item | Most recent FY | Prior FY |
|---|---|---|
| Revenue | $11,280 | $0 |
| Cost of goods sold | $4,819 | $0 |
| Net income (loss) | -$496,465 | -$1,562 |
| Total assets | $701,561 | $923,027 |
| Cash and equivalents | $133,679 | $243,453 |
| Accounts receivable | $0 | $0 |
| Short-term debt | $0 | $0 |
| Long-term debt | $0 | $0 |
| Taxes paid | $0 | $0 |
Two fiscal years as reported on the Form C cover sheet. 1 employees. Offered in 56 states.